Stay updated on Nivolumab for Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Nasopharyngeal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0 from the page.
    Difference
    0.0%
    Check dated 2026-02-06T09:21:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Introduced a Show glossary toggle and updated UI labels (including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') with a new page revision at v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T22:20:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T07:31:40.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The Locations section now includes new site entries for California, Florida, Illinois, Maryland, Minnesota, Missouri, and Hong Kong, and the separate 'California Locations', 'Florida Locations', 'Illinois Locations', 'Maryland Locations', 'Minnesota Locations', 'Missouri Locations', and 'Hong Kong Locations' blocks have been removed.
    Difference
    0.7%
    Check dated 2025-12-23T23:51:11.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate PubMed auto-fill and that the revision tag now shows Revision: v3.3.2, replacing the previous language about PubMed-derived lists and Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:05.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Removal of the government funding/operational status notice at the bottom of the page; core study information, endpoints, eligibility criteria, and contact details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:26:54.000Z thumbnail image

Stay in the know with updates to Nivolumab for Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Nasopharyngeal Cancer Clinical Trial page.